Health Trials

Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial

ConditionsThe Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKDEnd Stage Kidney Disease (ESRD)Sepsis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNavamindradhiraj University

About this trial

Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.

Eligibility criteria

Qualifiers

ESKD patients who have sepsis condition with high interleukin-6 (IL-6 > 50 pg/ml)

Disqualifiers

Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.

Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.

Trial design

Treatments tested in this trial

  • Super High-flux dialyzer (Elisio 19HDx)
  • High-flux dialyzer (Elisio 19H)

Treatment groups

202 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Navamindradhiraj University

Lead sponsor

Source ClinicalTrials.gov